StockData
BioAdaptives, Inc. logo

BioAdaptives, Inc. (BDPT) stock

BDPTOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 3/30
$0.00−0.00 (-5.56%)

Close on Oct 19, 2026Market cap $478.03KP/E –Yield –

BioAdaptives free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

BioAdaptives's free cash flow for the twelve months ending Dec 31, 2025 was -$534.03K. For fiscal 2025 it was -$534.03K.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$534.03K–
FY2024Dec 31, 2024-$249.52K–
FY2014Dec 31, 2014-$57.05K–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025-$155.83K–
Q3 FY2025Sep 30, 2025-$151.31K–
Q4 FY2024Dec 31, 2024-$100.54K–
Q3 FY2024Sep 30, 2024-$56.34K–

More BioAdaptives figures

See a number that looks wrong?